Sage Journals: Discover world-class research

Retricted access

Research article

First published 2010-12

IFN-γ Reduction by Tricyclic Antidepressants

Hubertus Himmerich, Stephany Fulda, Abigail J. Sheldrick [...]

The International Journal of Psychiatry in Medicine

Retricted access

Research article

First published 2008-10

Desvenlafaxine: Another “Me Too” Drug?

Michael A Sopko, Megan J Ehret, Marina Grgas

Annals of Pharmacotherapy

Retricted access

Research article

First published 2004-12

Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects

Elio Ciusani, Daniele F. Zullino, Chin B. Eap [...]

Journal of Psychopharmacology

Retricted access

Research article

First published 2002-07

Venlafaxine: the relationship between dose,plasma concentration and clinical response in depressive patients.

C. Charlier, E. Pinto, M. Ansseau [...]

Journal of Psychopharmacology

Retricted access

Research article

First published 2004-12

Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects

Elio Ciusani, Daniele F. Zullino, Chin B. Eap [...]

Journal of Psychopharmacology

Retricted access

Research article

First published 2007-08

Venlafaxine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Robert L. Findling, Laurence L. Greenhill, Nora K. McNamara [...]

Journal of Child and Adolescent Psychopharmacology

Retricted access

Research article

First published 1995-4

Venlafaxine: A Structurally Unique and Novel Antidepressant

W Alexander Morton, Susan C Sonne, Michael A Verga

Annals of Pharmacotherapy

Search results

IFN-γ Reduction by Tricyclic Antidepressants

Desvenlafaxine: Another “Me Too” Drug?

Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects

Venlafaxine: the relationship between dose,plasma concentration and clinical response in depressive patients.

Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects

Venlafaxine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Venlafaxine: A Structurally Unique and Novel Antidepressant